Skip to main content
. 2021 Jun 9;22(12):6220. doi: 10.3390/ijms22126220

Table 1.

Comparison of clinical features of patients with XP, XP neurological disease, XP/CS, and CS [11,12].

Clinical Features XP XP Neurological Disease XP/CS CS
Molecular defects XP-A, -B, -C, -D, -E, -F and XP-V XP-A and XP-D followed by XP-B, XP-G, and XP-F XP-B, XP-D, XP-G CS-A, CS-B
Skin sun sensitivity + + + +
Increased freckling + + + -
Sunlight—induced skin cancer + + + -
Photophobia + + + +
Anterior eye cancer + + + -
Retinal degeneration - - + +
Sensorineural deafness - + + +
Developmental delay - + + +
Progressive neurological degeneration - + + +
Primary neuronal degeneration - + - -
Demyelination of brain - - + +
Cerebral atrophy - + + +
Cerebellar atrophy - + + +
Calcification (basal ganglia) - - + +

“+”—indicated clinical feature is associated with the disease; “-”—this clinical feature does not observed.